Screening of intronic mutation IVS9+141A>G in an Indonesian patient with Gaucher disease

Rabbil Aji, Ika Lestari, Rizky Priambodo, Cut Hafifah, Damayanti Sjarif

Research output: Contribution to journalArticlepeer-review


Objective: Gaucher disease (GD) is an autosomal recessive lysosomal storage disorder caused by the accumulation of the glycolipid glucosylceramide encoded by the GBA gene in certain organs. At present, more than 460 GBA intronic mutations have been reported in several subpopulations worldwide, but many have never been reported in Indonesia. Here, we aimed to screen for intronic mutations of GBA that might be present in patients with GD in Indonesia. Materials and Methods: Blood samples from patients with and without GD were obtained from the National Dr. Cipto Mangunkusumo Referral Hospital, Jakarta, Indonesia. Genomic DNA samples from peripheral leukocytes were extracted, purified, and amplified using the polymerase chain reaction (PCR) with specific primers. Products of PCR were visualized by gel electrophoresis and were further sequenced to analyze the presence of mutations in intron (intervening sequence [IVS]) 9 of GBA. Results: A mutant allele was identified at IVS9+141A>G, discovered at nucleotide 9335 in IVS 9. This mutation had been reported in India before and was categorized as nonpathogenic. Conclusion: Our study may be used as supplemental information for the GD database in Indonesia and will also open new research opportunities for predicting splicing processes in other intronic variants among patients with GD in Indonesia.

Original languageEnglish
Pages (from-to)S123-S125
JournalJournal of Natural Science, Biology and Medicine
Issue number3
Publication statusPublished - Nov 2019


  • Gaucher disease
  • GBA gene
  • glucocerebrosidase
  • IVS9+141A>G mutation


Dive into the research topics of 'Screening of intronic mutation IVS9+141A>G in an Indonesian patient with Gaucher disease'. Together they form a unique fingerprint.

Cite this